Google Chrome
Safari
Firefox
Edge
Salmeterol Xinafoate
API Product
Product Status:
Commercial
Available Grades:
- 吸入剤用
Regulatory Status:
米国 DMF
欧州CEP
Production Sites:
- Hovione Loures
Product Type:
- LABA
- LAMA
CAS Number:
94749-08-3
Modes of Application:
- 吸入
Common Indications:
- 喘息
- 慢性閉塞性肺疾患
Last Inspection:
FDA May 2018
Hovione can customize Salmeterol Xinafoate for inhalation with an unrivalled range of particle size reduction technologies for the production of tailor made API, featuring a near-perfect particle size distribution reproducibility with a low span and amorphous content, providing highly stable API.
Hovione Salmeterol Xinafoate is approved in generic applications.
With a proven track record in developing and manufacturing high performance APIs Hovione offers a full range of API for inhalation, e.g. Fluticasone Propionate or Tiotropium Bromide.
This is not to be construed as a representation of non-infringement or as an offer to sell in those countries where such would constitute an infringement of third parties’ patent rights.
Highlight